Distribution of High Risk Human Pappiloma Virus Genotypes Among Women with Cervical Cancer in East Africa: Systematic Review
Journal of Family Medicine and Health Care
Volume 5, Issue 1, March 2019, Pages: 8-14
Received: Jun. 10, 2019; Accepted: Jul. 5, 2019; Published: Jul. 19, 2019
Views 192      Downloads 36
Authors
Matifan Dereje Olana, Department of Medical Laboratory Sciences, Ambo University, Ambo, Oromia, Ethiopia
Gemechis Tesso Kumburi, Department of Biochemistry, Ambo University, Ambo, Oromia, Ethiopia
Article Tools
Follow on us
Abstract
High- risk human papilloma viruses are the major etiological agent of cervical cancer, which is one of the leading cancers among women in sub-Saharan Africa. The aim of the present systematic review is to identify type distribution of high risk human Pappiloma viruses among women with cervical cancer in East Africa. The present systematic review was performed using published articles, which was accessed from electronic databases such as MEDLINE/PubMed, Google Scholar, EMBASE, CINAHL and Cochrane Central library. Eligible research articles were selected based on predetermined inclusion and exclusion criteria. Four studies, which fulfilled the inclusion criteria, were included in the present systematic review. The finding of the present systematic review revealed that the totals of 15 HR-HPV associated with invasive cervical cancer were identified from the current study setting. These HR-HPV genotypes include HPV 16, HPV 18, HPV 56, HPV 45, HPV 39, HPV 52, HPV 31, HPV 35, HPV 58, HPV 33, HPV 59, HPV 68, HPV 66, HPV 82 and HPV 73. According to the current systematic review the major genotype associated with cervical cancer in east Africa were HVP 16 followed by HPV 18 and HPV 45 respectively.
Keywords
High-risk Human Pappilloma Virus, Cervical Cancer, Genotype, East Africa
To cite this article
Matifan Dereje Olana, Gemechis Tesso Kumburi, Distribution of High Risk Human Pappiloma Virus Genotypes Among Women with Cervical Cancer in East Africa: Systematic Review, Journal of Family Medicine and Health Care. Vol. 5, No. 1, 2019, pp. 8-14. doi: 10.11648/j.jfmhc.20190501.12
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiology and Molecular Biology Reviews. 2004; 68 (2): 362–372.
[2]
Centers for Disease Control and Prevention. Genital HPV Infection—CDC Fact Sheet. Centers for Disease Control and Prevention. 2004.
[3]
Harald zur H: Papillomavirus infections - a major cause of human cancers. Biochimica et Biophysica Acta 1288 (1996) F55-F78.
[4]
Brisson J, Morin C, Fortier et al. Risk factors for cervical intraepithelial neoplasia: differences between low-and high- grade lesions. Am J Epidemiol 1994; 140: 700–710.
[5]
Bosch, F. X. & Munoz, N. The viral etiology of cervical cancer. Virus research 89, 183–190 (2002).
[6]
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM, the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 2003, 348: 518-27.
[7]
World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 1.1. ISBN 9283204298.
[8]
WHO: vaccine and diseases: Human papillomavirus, March 2018. Available from https://www.who.int/immunization /diseases/hpv/en/, accessed on 12/3/2019.
[9]
Husain RSA, Ramakrishna V: Global Variation of Human Papillomavirus genotypes and selected genes involved in cervical malignancies. Annals o f Global Health: VOL. 81, NO. 5, 20 15.
[10]
Bray Fr, Ferlay J, Soerjomataram I, L. Siegel R, Torre L, Jemal, A: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA CANCER J CLIN 2018; 68: 394–424.
[11]
WHO/ICO: Human papiloma virus and related cancers in Ethiopia. In Summary report; 2017.
[12]
Kiatpongsan S, Kim JJ (2014) Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries. PLoS ONE 9 (9): e106836. doi: 10.1371/journal.pone.0106836.
[13]
Elasbali AM, Din AH, Abdallah RA and Ahmed HG: Cervical and Oral Screening for HR-HPV types 16 and 18 among Sudanese Women Cervical Lesions. Infectious Agents and Cancer 2012 7: 17.
[14]
Leyh-Bannurah SM, Prugger C, Koning MN, Goette H and Lellé RJ: Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia. Infectious Agents and Cancer 2014 9: 33.
[15]
Salih MM, Safi ME, Hart K, Tobi K, Adam I: Genotypes of human papilloma virus in Sudanese women with cervical pathology. Infectious Agents and Cancer 2010 5: 26.
[16]
Menon S, Luchters S, Rossi R, Callens S, Kishor M, Bogers J and Broeck DV: Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: acrosssectional analysis. Virology Journal 2018 15: 54.
[17]
Luque AE, Hitti J, Mwachari C, Lane C, Messing S, Cohn SE, Adler D, Rose R, and Coombs R: Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women’s HIV Interdisciplinary Network (WHIN). Int J Infect Dis. 2010, 14 (9): 810–814.
[18]
Joanna Briggs Institute (JBI0) 2017: Joanna Briggs Institute Critical Appraisal checklist for prevalence Studies. http://joannabriggs.org/research/critical-appraisal-tools.html
[19]
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009, 6 (7): e1000097. doi: 10.1371/journal.pmed.1000097.
[20]
Bekele A, Baay M, Mekonnen Z Suleman S and Chatterjee S: Human papillomavirus type distribution among women with cervical pathology – a study over 4 years at Jimma Hospital, southwest Ethiopia. Tropical Medicine and International Health 2010, 15 (8): 890–893.
[21]
Wolday D, Derese M, Gebressellassie S, Tsegaye B, Ergete W, Gebrehiwot Y, Caplan O, Wolf D and Maayan S: HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia. Infectious Agents and Cancer 2018, 13: 28.
[22]
Ermel A, Qadadri B, Tong Y, Orang’o O, Macharia B, Ramogola-Masire D, Zetola N and Brown D: Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications. Infectious Agents and Cancer 2016 11: 56.
[23]
Abate E, Aseffa A, El-Tayeb M, El-Hassan I, Yamuah L, Mihret W, Bekele L, Ashenafi S, El-Dawi Nadia, Belayneh M, El-Hassan A, and Engers H: Genotyping of Human Papillomavirus in Paraffin Embedded Cervical Tissue Samples From Women in Ethiopia and the Sudan. Journal of Medical Virology 2013, 85: 282–287.
[24]
Banura C, Mirembe F, Katahoire A, Namujju P, Mbonye A and Wabwire F: Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review. Infectious Agents and Cancer 2011 6: 11.
[25]
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM, the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 2003, 348: 518-27.
[26]
Vuysta HD, Alemanyb L, Laceyd C, Chibweshae CJ, Sahasrabuddhef V, Banurag C, Dennyh L, and Parhami GP: The Burden of Human Papillomavirus Infections and Related Diseases in Sub-Saharan Africa. Vaccine, 2013; doi: 10.1016/j.vaccine. 2012.07.092.
[27]
Xu H, Wang K, Feng X, Dong S, Lin A, Zheng L and Yan W: Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and metaanalysis. Oncotarget, 2018, 9 (20): 15386-15397.
[28]
Sarma U, Mahanta J, Borkakoty B, Sarmah B: Distribution of Human Papilloma Virus Infections of Uterine Cervix among Women of Reproductive Age - a Cross Sectional Hospital-Based Study from North East India. Asian Pac J Cancer Prev 2015, 16 (4), 1519-1523.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186